Feasibility study of allogeneic mesenchymal stem cell therapy in patients with hypophosphatase

Not Applicable

Recruiting

• Conditions: Hypophosphatasia; D007014

• Registration Number: JPRN-jRCT1060210038
• Lead Sponsor: Taketani Takeshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1) Diagnosed as hypophosphatasia
2) Under 12 years old
3) Have or have been treated with asphotase alpha
4) Written consent of the surrogate has been obtained for participation in this study.

Exclusion Criteria

none

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HLA matching between commartial bone marrow donor database and participant

Secondary Outcome Measures

Name	Time	Method
HLA matching between donor database of Japan Marrow Donor Program and participant